IHC analyses revealed that high levels of PHB1 were expressed in the PHB1 over-expression group, accompanied by lower-intensity anti-Ki67, anti-cyclin D1, anti-CDK4, and anti-Bcl-2 staining, indicating low levels of NPC cell proliferation (Fig. 4k). The gene discussed is BCL2; the disease is nasopharyngeal carcinoma.